She studies the molecular mechanisms of signal transduction and oncogenic activation in the PI3K/mTOR pathways. She is also studying the isoprenoid pathway as a target of protozoan parasitic diseases.Dr. Gabelli holds a Ph.D. from Johns Hopkins University and completed postdoctoral research at Johns Hopkins before joining the faculty. She is a member of the Johns Hopkins Kimmel Cancer Center.